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ABSTRACT
Here, we report a long-distance interaction (LDI) as a
critical regulator of alternative splicing of Survival
Motor Neuron 2 (SMN2) exon 7, skipping of which is
linked to spinal muscular atrophy (SMA), a leading
genetic disease of children and infants. We show
that this LDI is linked to a unique intra-intronic struc-
ture that we term internal stem through LDI-1 (ISTL1).
We used site-specific mutations and Selective
20-Hydroxyl Acylation analyzed by Primer Extension
to confirm the formation and functional significance
of ISTL1. We demonstrate that the inhibitory effect of
ISTL1 is independent of hnRNP A1/A2B1 and PTB1
previously implicated in SMN2 exon 7 splicing. We
show that an antisense oligonucleotide-mediated se-
questration of the 30 strand of ISTL1 fully corrects
SMN2 exon 7 splicing and restores high levels of
SMN and Gemin2, a SMN-interacting protein, in
SMA patient cells. Our results also reveal that the 30
strand of ISTL1 and upstream sequences constitute
an inhibitory region that we term intronic splicing
silencer N2 (ISS-N2). This is the first report to dem-
onstrate a critical role of a structure-associated LDI
in splicing regulation of an essential gene linked to a
genetic disease. Our findings expand the repertoire
of potential targets for an antisense oligonucleotide-
mediated therapy of SMA.
INTRODUCTION
Alternative splicing is modulated by combinatorial control
exerted by overlapping linear motifs called exonic or
intronic splicing enhancers and silencers (ISSs) (1–3).
Although methods to deﬁne linear splicing motifs
continue to evolve (4–6), there is a growing appreciation
of the role of RNA structure in regulation of alternative
splicing (7–10). RNA secondary structure folding occurs
on a microsecond time scale (11,12), a rate that is faster
than polymerase II-mediated transcription elongation,
which is 100 nt per second (13). Therefore, terminal
stem-loops (TSLs), which represent the most prevalent
form of local structures, are formed as soon as the
nascent transcript emerges from the polymerase.
Multiple studies conﬁrm the role of TSLs in modulation
of alternative splicing (14–18). Evidence suggests that
internal stems formed by long-range interactions affect
pre-mRNA splicing as well (8,19,20). However, functional
validation of such interactions as critical checkpoints for
splicing regulation in the context of a human disease has
not been done.
Humans have two nearly identical copies of the Survival
Motor Neuron (SMN) gene: SMN1 and SMN2 (21). The
two SMN genes code for identical proteins; however,
SMN2 predominantly generates a shorter transcript
owing to skipping of exon 7, which produces a truncated,
unstable SMN (22,23). The inability of SMN2 to compen-
sate for the loss of SMN1 results in spinal muscular
atrophy (SMA), a debilitating childhood disease (24).
SMN2 exon 7 skipping is caused by a C-to-T mutation
at the sixth position (C6U in transcript) of exon 7 (25).
C6U weakens the 30 splice site (30 ss) owing to the loss
of an exonic splicing enhancer associated with SF2/ASF
and/or gain of an exonic splicing silencer associated with
hnRNP A1 [Figure 1, (29,30)]. Another SMN2-speciﬁc
mutation at the 100th position of intron 7 creates an ISS
associated with hnRNP A1 [Figure 1, (31)]. Sam68 and
PTB1 are two additional inhibitory proteins implicated in
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SMN2 exon 7 skipping [Figure 1, (28,32,33)]. Several
positive factors, including hnRNP G, hnRNP Q,
SRp30c, TDP43, TIA1 and Tra2-b1 stimulate SMN2
exon 7 inclusion [Figure 1, (27)].
An early in vivo selection study to unravel the
position-speciﬁc role of residues within exon 7 revealed
the suboptimal nature of its 50 ss (26). Subsequent
studies uncovered a series of negative cis-elements in
the vicinity of the 50 ss of exon 7, including ISS-N1, a
stem-loop structure (TSL2) and a GC-rich sequence that
partially overlaps with ISS-N1 [Figure 1, (16,34,35)].
The discovery of ISS-N1 was particularly signiﬁcant,
as it served as the ﬁrst example in which deletion of
an inhibitory intronic element fully restored SMN2
exon 7 inclusion even in the absence of the critical
positive regulatory elements within exon 7 (34).
Further, sequestration of ISS-N1 by an antisense oligo-
nucleotide (ASO) corrected SMN2 exon 7 splicing and
restored high levels of SMN protein in SMA patient
cells. Of note, different mechanisms may account for
the strong stimulatory effect of ISS-N1 deletion and
ASO-mediated ISS-N1 sequestration. For example,
deletion of ISS-N1 brings a TIA1-binding site (a
positive cis-element) close to the 50 ss of exon 7 (28),
whereas an ASO-mediated sequestration of ISS-N1 de-
stabilizes an inhibitory structure close to the 50 ss of
exon 7 (this study). Following the discovery of ISS-N1
in 2006, an unprecedented number of in vivo studies
independently conﬁrmed the therapeutic efﬁcacy of
ISS-N1-targeting ASOs (36–39).
Figure 1. An account of transacting factors and cis-elements including RNA secondary structure that regulate SMN2 exon 7 splicing. (A)
Diagrammatic representation of cis-elements located within exon 7 and the ﬁrst 104 nt of intron 7 of SMN2. The sequence of SMN2 exon 7 and
adjacent intron 7 are given. Numbering of nucleotides starts from the beginning of intron 7. Positive cis-elements/transacting factors that promote
exon 7 inclusion and negative cis-elements/transacting factors that promote exon 7 skipping are indicated by (+) and (), respectively. Exinct,
Conserved tract and 30-Cluster were identiﬁed by in vivo selection of the entire exon 7 (26). TSL2 structure sequesters the 50 ss of exon 7 (16). Element
2 and binding sites for SF2/ASF, hnRNP A1/A2, Sam68, hnRNP Q, Tra2-b1, TDP-43, hnRNP G and SRp30c were described by others (27). TIA1
was shown to bind to intron 7 U-rich Clusters (URCs) 1 and 2 and promote exon 7 inclusion (28). ISS-N1, along with an overlapping GC-rich
sequence and the 10C involved in LDI all contribute toward exon 7 skipping (27). (B) Schematic representation of RNA secondary structure of
SMN2 intron 7. The schematic is based on chemical structure probing performed in this study (see Figure 6). A deﬁning feature of the RNA
secondary structure of SMN2 intron 7 is the presence of the three adjacent internal stems formed by LDIs (ISTLs). The adjacent 30-strands of ISTL1,
ISTL2 and ISTL3 constitute ISS-N2, a novel target for splicing correction in SMA (described later). Of note, 10C is locked in ISTL1 and base pairs
with the 290th position of SMN2 intron 7. A sequence identical to LS-1 has been shaded. Descriptions of abbreviations are given in Supplementary
Table S1.
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We have previously reported a unique long-distance
interaction (LDI) between a cytosine residue at the 10th
position (10C) of SMN2 intron 7 and a downstream
intronic sequence separated from 10C by hundreds of nu-
cleotides (40). The most surprising aspect of this discovery
was the position-speciﬁc role of 10C. An ASO (F14) that
sequestered the ﬁrst 14 residues (including 10C) of ISS-N1
promoted SMN2 exon 7 inclusion, whereas another ASO
(L14) that sequestered the last 14 residues (excluding 10C)
of ISS-N1 increased SMN2 exon 7 skipping. Deletion or
substitution of 10C fully abrogated the inhibitory effect of
L14, conﬁrming that the negative impact of this ASO is
associated exclusively with the unsequestered 10C. The ﬁrst
indirect support linking 10C to an LDI came from experi-
ments in a heterologous system, where the negative effect
of L14 on exon 7 splicing was not recapitulated, despite
the system harboring the entire SMN2 exon 7 and ﬂanking
intronic sequences, including ISS-N1 (40). Subsequent ex-
periments revealed that 10C engages in a LDI with down-
stream sequences within the 30 portion of SMN2 intron 7.
Indeed, deletion of these sequences transformed L14 into a
stimulatory ASO (40). These ﬁndings offered a unique
opportunity to uncover the molecular basis of a rare
LDI in the context of a leading genetic disease.
Here, we report the mechanistic basis of the
10C-mediated LDI, which we found to be facilitated by
an intricate arrangement of sequence and structural
motifs within SMN2 intron 7. Using deletions and site-
speciﬁc mutations combined with chemical structure
probing, we demonstrate that the 10C-mediated LDI is
linked to a unique RNA structure. We also show that
the inhibitory effect of the 10C-mediated LDI is independ-
ent of the widely expressed hnRNP A1/A2B1, and PTB1
proteins that were previously implicated in skipping of
SMN2 exon 7. These results provide the ﬁrst example in
which a deep intronic sequence associated with a RNA
structure supported by a unique LDI modulates alterna-
tive splicing in a major genetic disease. In addition, we
demonstrate that a RNA structure within an intron
could serve as an effective target for an ASO-mediated
splicing correction in SMA.
MATERIALS AND METHODS
Minigenes and antisense oligonucleotides
SMN2 mutant minigenes were generated by PCR using a
strategy described earlier (26). The identity of the newly
constructed minigenes was veriﬁed by sequencing. All
primers for cloning were from Integrated DNA
Technologies. Reagents for PCR and cloning were from
New England Biolabs. RNA ASOs were synthesized by
Dharmacon Inc. and incorporated a phosphorothioate
backbone and 20-O-methyl modiﬁcations at each base
[Supplementary Table S2, (34)].
Cell culture
All tissue culture media and supplies were purchased from
Life Technologies. Human cervical adenocarcinoma
(HeLa) cells obtained from the American Type Culture
Collection were cultured in Dulbecco’s modiﬁed Eagle’s
medium supplemented with 10% fetal bovine serum.
Primary patient ﬁbroblasts from an SMA type I patient
(repository number GM03813) were obtained from Coriell
Cell Repositories. These cells were grown in minimal es-
sential medium (MEM, catalog # 10370) supplemented
with 1X GlutaMAX-I and 15% fetal bovine serum.
Cell transfection
Transient transfections of cells with plasmid DNA and/or
ASOs were performed using Lipofectamine-2000 (Life
Technologies) following the manufacturer’s recommenda-
tions. HeLa cells were plated at a density of 1.1 105
cells per well of 24-well plates. The next day, cells were
cotransfected with 0.1 mg of a given minigene and 50 nM
of an ASO of interest. The total amount of transfected
nucleic acid was maintained constant (0.8 mg) by adding
the control ASO [Supplementary Table S2, (40)]. The
growth medium was changed 6 h post-transfection. In
the case of primary ﬁbroblasts, depending on the
amount of cells needed for the analysis, GM03813 cells
were plated in either 6-well plates or 100 mm dishes at a
density of 1.3 105 cells per well or 9 105 cells per dish,
respectively. The next day, GM03813 cells were trans-
fected with ASOs. ASO concentrations varied and are
indicated in the legend of Figure 11. The growth
medium was replaced 6 h after transfection. For isolation
of total RNA only, HeLa and GM03813 cells were lysed
directly in tissue culture plates 24 h post-transfection
using Trizol Reagent (Life Technologies). For simultan-
eous RNA and protein analysis, transfected GM03813
cells were collected 48 h post-transfection by scraping.
One-third of the cells were taken for RNA isolation with
Trizol, and the rest were used for protein isolation and
western blotting.
ASO transfection combined with protein knockdown
Proteins of interest were knocked down using siRNAs
(ON-TARGETplus SMART pool; Dharmacon Inc.). An
ON-TARGETplus non-targeting pool served as a control
siRNA. To knockdown proteins of interest, HeLa cells
were reverse transfected with siRNAs twice with an
interval of 48 h. For each siRNA transfection, a
siRNA-Lipofectamine-2000 complex was prepared follow-
ing the manufacturer’s suggestions, combined with HeLa
cell suspension containing 1 106 cells in a total volume
of 2ml, and then the cells were seeded in one well of a
6-well plate. For simultaneous transfection of siRNAs
against hnRNP A1 and hnRNP A2B1, two wells were
seeded, as simultaneous depletion of hnRNP A1 and
hnRNP A2B1 proteins had a negative effect on cell
survival. For the ﬁrst transfection, the ﬁnal concentration
for individual siRNAs was 80 nM and 40 nM each when
siRNAs against hnRNP A1 and hnRNP A2B1 were trans-
fected together. The next day, the transfected cells were
trypsinized and transfered to 60mm dishes. The second
reverse transfection of HeLa cells with siRNAs was per-
formed 48 h after the ﬁrst one essentially as described
earlier in the text, except that the siRNA concentration
was increased to 100 nM for individual siRNAs and to
50 nM each when siRNAs against hnRNP A1 and
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hnRNP A2B1 were transfected together. Twenty-four
hours after the second siRNA transfection, HeLa cells
were trypsinized and seeded in 24-well plates to be trans-
fected with the ASOs of interest the next day. The remain-
ing cells were returned to 6-well plates to be collected
22 h later for making cell lysates to monitor the efﬁ-
ciency of protein knockdown. Three wells of a 24-well
plate were seeded for each siRNA transfection. The
density of plating per well was 1.4 105 cells for HeLa
transfected with a control siRNA, 1.6 105 cells for
HeLa transfected with individual siRNA against hnRNP
A1, hnRNP A2B1 or PTB1 and 1.7 105 cells for HeLa
co-transfected with siRNAs against hnRNP A1 and
hnRNP A2B1. HeLa cells seeded in 24-well plates were
transfected 24 h later with 100 nM ASO of interest along
with corresponding siRNA using Lipofectamine-2000
followed by cell lysis 24 hours later and isolation of
total RNA.
In vivo splicing assay
Total RNA was isolated using Trizol Reagent following
the manufacturer’s instructions. cDNA was generated as
described previously (40). Minigene-speciﬁc spliced
products were ampliﬁed using Taq DNA polymerase
and the P1 and P2 primer pair [Supplementary Table S3,
(34)]. For PCR ampliﬁcation of endogenous SMN, either
P25 and P31 or N-24 and P2 primer pairs were used
[Supplementary Table S3, (28,34)]. Cloning and
sequencing conﬁrmed the identity of splice variants
ampliﬁed by RT-PCR (26). To accurately determine the
relative abundance of splice variants, reduced cycles of
PCR reactions were performed either in the presence of
a trace amount of [a-32P] dATP (3000Ci/mmole, Perkin-
Elmer Life Sciences) or with the P2 primer labeled at the
50-end with 32P. To distinguish SMN1 and SMN2 splice
isoforms, PCR products ampliﬁed with primers P25 and
P31 were subjected to overnight DdeI digestion, followed
by phenol:chloroform extraction and ethanol precipita-
tion (28). Quantiﬁcation and analysis of splice products
were performed using an FPL-5000 Image Reader and
Multi Gauge software (Fuji Photo Film Inc.). Results
were conﬁrmed by at least three independent experiments.
The percentage values of exon 7 skipping given in ﬁgures
were calculated from the shown representative gel.
Western blot analysis
HeLa cells (3 105) were harvested, and cell lysates were
prepared similarly as described before (34). One-seventh
of each lysate was used for one blot. Whole-cell extracts
from GM03813 cells were prepared as described previ-
ously (41). Protein concentrations were determined using
the Bio-Rad Protein Assay Dye Reagent Concentrate
(Bio-Rad). Protein samples were resolved on 8 or 10%
SDS–polyacrylamide gels and transferred onto
polyvinylidene ﬂuoride membrane (Bio Trace PVDF,
Pall Life Sciences). The following primary and secondary
antibodies were used for western blot analysis: mouse
monoclonal anti-PTB1 (Abcam), mouse monoclonal
anti-hnRNP A1, clone 9H10 (Abcam), mouse monoclonal
anti-hnRNP A2B1, clone DP3B3 (Abcam), mouse
monoclonal anti-SMN, clone 8 (BD Transduction
Laboratories), mouse monoclonal anti-Gemin2, clone
2E17 (Sigma), mouse monoclonal anti-GAPDH, clone
6C5 (Abcam), rabbit polyclonal anti-Actin (Sigma-
Aldrich), goat anti-mouse horseradish peroxidase-
conjugated antibody (Jackson Immunoresearch) and
donkey anti-rabbit horseradish peroxidase-conjugated
antibody (GE Healthcare). Immunoreactive proteins
were visualized with Clarity Western ECL substrate
(Bio-Rad), SuperSignal West Dura Extended Duration
Substrate or SuperSignal West Femto Maximum
Sensitivity Substrate (Thermo Scientiﬁc). Membranes
were stripped using Restore Western Blot Stripping
Buffer (Thermo Scientiﬁc) and re-probed for proteins of
interest. The membranes were scanned using the UVP
BioSpectrum AC Imaging System (UVP). Results were
conﬁrmed by at least three independent experiments.
RNA structure probing
RNA secondary structure was probed using Selective
20-Hydroxyl Acylation analyzed by Primer Extension
(SHAPE) following recommendations provided in (42).
The 1-methyl-7-nitroisatoic anhydride (1M7) was
synthesized as described (43). RNA substrates for struc-
ture probing were in vitro transcribed using T7
MEGAshortscript kit (Ambion) following the manufac-
turer’s recommendations. Templates for T7 in vitro tran-
scription were prepared as follows. Sequences that
contained the last 17 nt of exon 7 and all of intron 7
were ampliﬁed by PCR using the primer pair 50T7-Xba-2
(50-ATA TAT TCT AGA TAA TAC GAC TCA CTA
TAG GGA TTC CTT AAA TTA AGG AGT AAG
TC-30) and 30Hind-2 (50-ATA TAT AAG CTT TTC
TGC AAA TGA GAA ATT AGA ACC AG-30) and
either wild-type SMN2I6 minigene (26) or internal
stem through LDI-1 (ISTL1)-M4 mutant (this study) as
a template. The resulting PCR fragments were digested
with XbaI and HindIII and cloned into the pUC19
vector to generate the plasmid constructs T7-TSL2-In7
and T7-TSL2-ISTL1-M4. The plasmids were linearized
with HindIII and used as tempates for RNAs synthesized
in an overnight T7 transcription reaction. The DNA
template was removed by DNase treatment followed by
phenol:chloroform extraction, and RNA was recovered by
ethanol precipitation, dissolved in water and further
puriﬁed by centrifugation through a gel-ﬁltration Micro
Bio-spin P-30 Chromatography column (Bio-Rad).
Primers used for extension reactions are listed in
Supplementary Table S4. Extension primers (60 pmol
each) were 50-end-labeled using [g-32P]ATP (6000Ci/
mmol) and T4 polynucleotide kinase (New England
Biolabs), phenol:chloroform extracted, and centrifuged
through a gel-ﬁltration Micro Bio-spin P-30 Chroma-
tography column to remove unincorporated [g-32P]ATP.
The eluted sample was evaporated under vacuum to
reduce the volume to 5 ml to which 10 ml of formamide
gel-loading buffer (Ambion) was added. End-labeled
primers were then puriﬁed on denaturing 15% polyacryl-
amide gels by the ‘crush and soak’ method (16). The
elution was done overnight at 37C. Primers were
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ethanol precipitated, dissolved in 70 ml of water and
centrifuged through a Micro Bio-spin P-30 Chromatog-
raphy column. Of note, 1 ml of recovered primer was
used for each 5 ml of primer extension reaction.
Before structure probing RNA was refolded as follows.
In all, 16 pmol RNA with the control ASO (40) or ASO of
interest was heated to 95C for 2min in 30mM Tris–HCl
(pH 8.0) and snap-cooled on ice. The amount of ASO used
was 160 pmol for F14, L14 and ASO-M. The amount was
increased to 204 pmol for ASO-D. Folding was performed
in a total volume of 72 ml [100mM Tris–HCl (pH 8.0),
100mM NaCl and 10mM MgCl2] at 37
C for 20min
after which time, the reaction was split into two aliquots
(36ml each), and the incubation continued for another
10min. Four microliters of either 1M7 (100mM in
DMSO) or DMSO (control) were then added to the
36 ml of RNA folding reaction, and the mixture was
incubated at 37C for 2min. Each modiﬁcation reaction
was then transferred to a tube containing 158 ml of water,
20 ml of potassium acetate [3M (pH 5.5)], 0.8 ml of 500mM
EDTA (pH 8.0) and 1.2ml of GlycoBlue (15mg/ml,
Ambion). RNA was recovered by ethanol precipitation
and dissolved in 10 ml of water. The 1M7 modiﬁcation
sites were analyzed by primer extension using
SuperScript III RTase (42). Brieﬂy, modiﬁed RNA (1 ml)
was mixed with 50-end-labeled primer of interest (1 ml), 1 ml
of water, 0.25ml of 5X RT buffer and 0.25 ml of dNTP
mixture (10mM each). The mixture was heated to 65C
for 5min and snap-cooled on ice. One microliter of RT
mix (four parts 5X RT buffer and one part 0.1M DTT)
and 0.5 ml of SuperScript III RTase (100U/ml) were then
added to the primer extension reaction. The reaction was
incubated for 2min at 45C and 30min at 55C. To
prevent RTase falloffs at positions 292 and 293 routinely
observed with extension primer#17 and primer#315, ASO-
D (5 pmol) was added to the reaction mixture before the
denaturation step. Denaturation itself was performed at
95C for 2min instead of at 65C for 5min. Also, before
RTase addition, the reaction was incubated for 5min at
45C to allow ASO-D to invade the ISTL1 structure and
release its 30 strand for primer extension. To generate
sequencing ladders, primer extension reactions were per-
formed as described earlier in the text, except that 0.5 ml of
a given ddNTP (10mM) was added per 5 ml of reaction
and 40 ng of the wild-type RNA substrate was used as a
template. For the primer extension step, the reactions were
incubated for 2min at 45C and 15min at 55C. To
degrade RNA after completion of primer extension,
0.5ml of 2M NaOH was added to the reaction, and the
mixture was heated at 95C for 5min. The mixture was
then allowed to cool to room temperature, and 1 ml of 1M
unbuffered Tris–HCl solution was added to neutralize the
pH. The products of the primer extension reaction were
resolved on denaturing 6% polyacrylamide gels and
visualized by autoradiography using a FPL-5000 Image
Reader.
Band intensities were quantiﬁed using Multi Gauge
software (Fuji Photo Film Inc). First, 1M7 reactivity for
each position was calculated by subtracting the control
(DMSO) band intensity from the ‘1M7-modiﬁed’ band
intensity. For each extension primer, the reactivity of
nucleotides was then normalized relative to the most
reactive position, which was assigned a value of 1.
Nucleotides with normalized reactivity between 0.3 and
0.5 were considered to be moderately reactive with 1M7,
whereas nucleotides with normalized reactivity above 0.5
were considered to be highly reactive with 1M7.
RESULTS
Characterization of intronic sequences involved in LDI
We previously reported that the 10C-mediated LDI is
modulated by sequences from the 195th to 306th (Area
1) and 325th to 405th (Area 2) positions of SMN2
intron 7 [Figure 2A, (40)]. To understand the mechanistic
basis of the 10C-mediated LDI, we thought it essential to
link the L14-induced inhibitory effect of 10C to the
smallest possible sequence. For this, we generated a set
of 23 SMN2 minigenes carrying 20 nt long overlapping
deletion mutations encompassing Area 1 and Area 2
(Figure 2A). We then co-transfected HeLa cells with
these minigenes and F14 or L14 and determined the
splicing pattern of exon 7 at 24 h post-transfection. As
shown in Figure 2B, L14 increased exon 7 skipping in the
majority of mutants except 271–290, 281–300 and
291–310, and to a lesser extent 262–281, whereas F14
caused predominant exon 7 inclusion in all cases. These
results reﬁned the region of the LDI as a single sequence
stretch between positions 271 and 300 within Area 1; we
consider it to be the primary site of LDI. Consistently,
L14 retained the inhibitory effect on exon 7 splicing in
SMN2 minigenes carrying large deletions outside of the
identiﬁed site, namely, spanning the region from position
93 to 281 and position 330 to 412 (Figure 2B, lanes 22–33).
Of note, these large deleted sequences fold into independ-
ent secondary structures or modules (Modules 1, 2 and 3;
Figure 2A) as determined by structure probing (described
later). To summarize, our results of large deletions and the
20 nt long overlapping deletions narrowed the primary site
of the 10C-mediated LDI to an area between the 282nd
and 300th positions of intron 7.
To further deﬁne the sequence motif that interacts with
10C, we examined the splicing pattern of SMN2 mutants
carrying 10 nt long overlapping deletions from the 261st to
320th positions of intron 7 (Figure 3A, upper panel). As
expected, F14 effectively stimulated exon 7 inclusion in all
11 mutants examined, whereas L14 inhibited exon 7 inclu-
sion in all but four mutants (281–290, 286–295, 291–
300, and to a lesser extent 296–305) (Figure 3A, lower
panel). These results further narrowed the primary site of
the 10C-mediated LDI to a single stretch of 15 nt from the
286th to 300th positions of intron 7 (Figure 3A, upper
panel). Also, underscoring the inhibitory nature of this
sequence, the 10 nt long overlapping deletions within this
region themselves produced a noticeable stimulatory effect
on SMN2 exon 7 splicing (Figure 3A, lanes 1, 7, 10, 13
and 16).
To continue our effort to ﬁnd the smallest possible
motif that is engaged in the LDI with 10C, we constructed
a set of mutants carrying 5 nt long overlapping deletions
within the sequence spanning from the 284th to 300th
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positions of SMN2 intron 7 (Figure 3B, upper panel) and
examined their splicing pattern in the presence of F14 or
L14. We identiﬁed three overlapping deletion mutants
(287–291, 290–294 and 293–297) in which the
ability of L14 to increase skipping of exon 7 was lost
(Figure 3B, lower panel). Thus, the primary site of the
LDI was reduced to a single 7 nt long sequence, AGCA
GAC, from the 289th to 295th positions of intron 7
(Figure 3B, upper panel). We also performed a parallel
experiment using SMN2 mutant minigenes that carried
Figure 2. Identiﬁcation of the primary site of the 10C-mediated LDI. (A) Diagrammatic representation of 20 nt long overlapping deletions within
SMN2 intron 7. The sequence of the ﬁrst 40 nucleotides of intron 7 is given at the top, with F14 and L14 target sites within ISS-N1 indicated.
Deletions are shown as lines. Mutants’ names are given on the left. Numbers in mutants’ names represent the positions at which deletions were made.
The effect of F14 and L14 on splicing is indicated on the right with (+) (promotes exon 7 inclusion) and () (promotes exon 7 skipping). (B) In vivo
splicing pattern of the wild-type SMN2 minigene and the representative deletion mutants from panel (A) in the presence of the indicated ASO. Exon
7-included (+) and exon 7-skipped () spliced products are marked. Control represents transfection with 10mer ASO (Supplementary Table S2).
Results were analyzed as described in (26). Ex7, exon 7.
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Figure 3. Characterization of the smallest motif of the 10C-mediated LDI. Intron 7 sequences of 10- (A), 5- (B) and 3 nt long (C) overlapping
deletion mutants are shown with deletions indicated as dashed lines. Nucleotide numbering starts from the beginning of intron 7. Mutants’ names are
given on the left. Numbers in mutants’ names represent the positions that were deleted. The effect of F14 and L14 on splicing is indicated similarly as
in Figure 2. The region determined to be an interacting partner of 10C is highlighted. In vivo splicing patterns of the wild-type SMN2 minigene and
the representative deletion mutants in the presence of the indicated ASOs are given in the bottom panels. Control ASO was the same as described in
Figure 2. Results were analyzed as described in (26).
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3 nt long overlapping deletions within the sequence
spanning from the 286th to 298th positions of intron 7
(Figure 3C, upper panel). The results of this experiment
identiﬁed the same 7 nt long motif, AGCAGAC, from
position 289 to position 295 as the core site of the 10C-
mediated LDI (Figure 3C).
The site of LDI maps to a unique RNA secondary
structure
To assess the position-speciﬁc impact of residues involved
in the interaction with 10C, we examined the effect of point
mutations in a 10 nt long sequence stretch between
intronic positions 288 and 297 on splicing of SMN2
exon 7 (Figure 4). This sequence contains the newly
identiﬁed site of the 10C-mediated LDI with a few
upstream and downstream residues. Interestingly, all but
1 nt of this sequence also constitute the 30 strand of a mfold
(44) predicted secondary structure that we call internal
stem through LDI-1 (ISTL1) (Figure 4A). The 50 strand
of ISTL1 incorporates 10C. Consistent with the
anticipated inhibitory role of ISTL1, a number of point
mutations within the 30 strand of ISTL1 caused an im-
provement in SMN2 exon 7 inclusion (Figure 4B). At
the same time, an A to G substitution at the 289th
position, which is predicted to extend the size of the
ISTL1 duplex by 1 bp, produced a strong inhibitory
effect on SMN2 exon 7 splicing (Figure 4B, lane 6). This
ﬁnding further underscored the inhibitory role of ISTL1.
We next examined the effect of F14 and L14 on splicing
of exon 7 in SMN2 minigenes carrying point mutations
described in Figure 4B. L14 produced a stimulatory effect
on exon 7 splicing in all SMN2 minigenes with point mu-
tations in the sequence spanning the 290th–295th pos-
itions of SMN2 intron 7 (Figure 4C). Therefore, we
conclude that this sequence (GCAGAC) constitutes the
LDI partner of 10C. To emphasize the sequence-speciﬁc
and position-dependent nature of the 10C-mediated LDI,
we term the GCAGAC motif spanning the 290th–295th
positions of intron 7 as LDI Site-1 or LS-1 (Figure 4C). As
all six residues of LS-1 fall within the 30 strand of ISTL1
(Figure 4A), we attribute the stimulatory effect of L14 on
exon 7 splicing in LS-1 mutants to the destabilization of
ISTL1. Remarkably, deletion of LS-1 but not an identical
upstream GCAGAC motif abrogated the 10C-mediated
LDI (Supplementary Figure S1). These results underlined
the requirement of a speciﬁc sequence motif at a precise
location within intron 7 for the interaction with 10C. These
results are also consistent with a role of RNA structure in
which speciﬁc positioning of LS-1 in the context of ISTL1
facilitates the LDI.
Role of ISTL1 in regulation of SMN2 exon 7 splicing
To evaluate the impact of the ISTL1 structure on exon 7
splicing, we generated an SMN2 minigene with a double
mutation (288U/289G), which is predicted to extend the
length of ISTL1 by 3 bp. This mutant showed greatly
increased exon 7 skipping as compared with the wild-
type construct (Figure 5A, lane 4). Furthermore, another
minigene mutant, ISTL1-M4, which carried four substitu-
tions (286G/288U/289G/298A), and therefore is predicted
to have at least a 13 bp long ISTL1, showed near-total
skipping of exon 7 (Figure 5A, lane 7), conﬁrming that
the inhibitory effect of ISTL1 is proportional to the size of
the stem. In both mutants, the target site of F14 is par-
tially sequestered by ISTL1. Consequently, in both
mutants, F14 had a diminished stimulatory effect on
exon 7 splicing (Figure 5A, lanes 5 and 8). We also
compared the effect of single nucleotide substitutions at
the 286th, 288th, 289th and 298th positions of intron 7.
Although both 289G and 298A mutants are predicted to
extend ISTL1 by 1 bp, only 289G showed a noticeable
increase in SMN2 exon 7 skipping (Figure 5A, lanes 16
and 19). This difference could be due to the fact that the
A:U base pair formed by 298A is weaker than the G:C
base pair formed by 289G (Figure 5A, upper panel). As
expected, 288U and 286G mutations that did not increase
the size of ISTL1 had no appreciable gain in the inhibitory
effect on SMN2 exon 7 splicing (Figure 5A, lanes 10 and
13).
To functionally validate the role of ISTL1 on SMN2
exon 7 splicing, we tested the effect of compensatory mu-
tations. In particular, we substituted U for C at the 8th
(8C) and C for G at the 10th (10G) positions of SMN2
intron 7. The 8C and 10G mutants had stimulatory and
inhibitory effects on exon 7 splicing, respectively
(Figure 5B, lanes 4 and 13). The unexpected negative
effect of the 10G mutation could be due to creation and/
or strengthening of an existing inhibitory element. Similar
to point mutations within the 30 strand of ISTL1
(Figure 4), these mutations are predicted to destabilize
ISTL1. Consistently, L14 lost its inhibitory effect and
promoted inclusion of exon 7 in both 8C and 10G
mutants (Figure 5B, lanes 6 and 15). These results
further supported the hypothesis that destabilization of
ISTL1 is necessary to abrogate the 10C-mediated LDI.
In the context of the wild-type SMN2 intron 7, 8U and
10C residues are predicted to base pair with 292A and
290G, respectively. Mutations at either the 290th or
292nd positions abrogated the negative effect of L14
(Figure 4C; Figure 5B, lanes 9 and 18). We predicted
that in the minigenes 8C/292G and 10G/290C that carry
restored ISTL1, L14 would either regain its negative effect
on exon 7 splicing or suppress the stimulatory effect it
produced in minigenes carrying single nucleotide muta-
tions. Indeed, L14 noticeably increased exon 7 skipping
in the 8C/292G mutant and suppressed the stimulatory
effect in case of 10G/290C (Figure 5B, lanes 12 and 21).
These results provided strong evidence in support of the
modulatory role of ISTL1 structure in SMN2 exon 7
splicing.
Structure probing supports ISTL1 formation
To validate the formation of ISTL1, we used SHAPE, a
powerful chemical structure probing technique (42). In
this assay, 1M7 modiﬁes the freely available 20-hydroxyl
groups (of sugar moieties) of nucleotides. In general,
residues located in loops and bulges are reactive,
whereas residues that form stems or engage in high-
order interactions are protected from modiﬁcation. We
performed all our structure probing experiments using a
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467 nt long RNA harboring TSL2, a structure formed at
the 30-end of exon 7 (16), and the entire intron 7. The
secondary structure of SMN2 intron 7 deduced from the
SHAPE analysis showed a substantial overlap with the
predicted secondary structure (Figure 6). According to
our results, intron 7 folds into several hairpins (TSLs)
and internal stems formed by LDIs (ISTLs).
Importantly, the results of SHAPE validated the forma-
tion of ISTL1 (Figure 6A). For instance, 14 of 16 residues
of ISTL1 were largely inaccessible for modiﬁcation. We
detected some degree of modiﬁcation of 3A and 293G that
are located at the terminal position and in the middle of
ISTL1, respectively. Of note, examples of SHAPE reactiv-
ity for nucleotides located within a stem have been
Figure 4. Effect of point mutations within the smallest motif associated with the 10C-mediated LDI. (A) Diagrammatic representation of regulatory
cis-elements/transacting factors and their relative arrangement in the context of SMN2 intron 7. The sequences of the ﬁrst 25 nt and from the 285th
to 300th positions of intron 7 are given. The region targeted for single-nucleotide substitutions is highlighted. (B) In vivo splicing pattern of SMN2
mutants with single-nucleotide substitutions. Numbers and letters at the top of the gel represent the positions and the type of substitutions within
intron 7. Spliced products are the same as those indicated in Figure 2B. Results were analyzed as described in (26). (C) Bar diagram showing
the percentage of exon 7 skipped in the presence of the control ASO (blue), F14 (green) and L14 (red). Control ASO was the same as described in
Figure 2. Error bars represent standard deviations (minimum of three replicates). Numbers and letters at the bottom of the bar diagram represent
the positions and the type of substitutions within intron 7. Every non-wild-type nucleotide substitution within the highlighted LS-1 abrogated
the negative effect of L14.
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reported (45,46). Validating the formation of TSL2, three
base pairs in the middle of the stem of TSL2 were com-
pletely protected from modiﬁcation (Figure 6A). We did
observe accessibility of additional residues at the most
ﬂexible positions such as loop closing and the base of
the stem of TSL2 (Figure 6A).
The probed structure localized ISTL1 adjacent to two
internal stems, which we designated as ISTL2 and ISTL3
(Figure 6A). The sequence stretch connecting the 50 strand
of ISTL1 with the 50 strand of ISTL2 folds into a hairpin
structure (TSL3), which partially sequesters the previously
reported binding sites of hnRNP A1/A2B1 and TIA1
Figure 5. Effect of structure-associated mutations on the 10C-mediated LDI. (A) Upper panel shows diagrammatic representation of predicted ISTL1
strengthened by mutations indicated in lower-case letters and highlighted in red. New base pairs formed owing to these mutations are shown as red
lines. Each minigene was assigned a name and a number as shown at the top of each structure. In vivo splicing patterns of minigenes in the presence
of the indicated ASOs are shown in the bottom panel. Spliced products are the same as those marked in Figure 2B. Control ASO was the same as
described in Figure 2. Results were analyzed as described in (26). (B) Upper panel shows diagrammatic representation of the predicted ISTL1
destabilized or restored by mutations indicated in lower-case letters and highlighted in green. Restored base pairs formed due to the mutations are
shown as green lines. Other descriptions are same as in panel A.
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proteins (Figure 6A). A few nucleotides in the predicted
stem of TSL3 were found to be accessible for modiﬁcation.
These include a U residue (25U) in the loop-closing base
pair, a G residue (39G) in the wobble base pair and an A
residue (18A) in the neighboring base pair (Figure 6A).
Residues immediately upstream and downstream of
TSL3 are located within internal loops (Figure 6A). It is
likely that the formation of these loops is dictated by the
topological constraints imposed by ISTL1 and ISTL2. We
also identiﬁed two regions where the SHAPE results did
not corroborate with the mfold-predicted structure. These
regions constitute Modules 1 and 2 that occupy a major
portion of intron 7 (Figure 6). We conclude that the for-
mation of ISTL1 is independent of these modules, as their
deletion did not abrogate the inhibitory effect of L14
(Figure 2). Another structural module, Module 3,
deletion of which had no consequences on the negative
effect of L14, showed substantial agreement between the
experimentally derived and the mfold-predicted structure
(Figure 6). Simultaneous deletions of Modules 1, 2 and 3
retained the inhibitory effect of L14 (Figure 2), suggesting
that formation of ISTL1 is feasible even in the context of a
short intron 7.
To further conﬁrm the formation of ISTL1, we
compared the SHAPE proﬁles of the wild-type and
ISTL1-M4 RNAs. As predicted, ISTL1-M4 RNA
showed a signiﬁcantly decreased 1M7 reactivity of the
1A, 1G, 2U, 3A 11C, 12A, 13 G and 14C nucleotides
that are located in the extended 50 strand of ISTL1 (Figure
7A, compare lanes 6 and 7; Figure 7C, upper panel).
SHAPE results also indicated that the extended stem in
ISTL1-M4 RNA caused perturbations in several local
structures. For instance, multiple residues involved in
the formation of TSL3 became accessible for modiﬁcation
by 1M7 [Figure 7A and C (upper panel)]. In addition,
ISTL2 became destabilized as indicated by the increase
in 1M7 modiﬁability of residues in its 50 strand, particu-
larly at positions 51 and 56 [Figure 7A and C (upper
panel)]. To obtain additional validation that the 50 and
30 strands of ISTL1 are protected from modiﬁcations
owing to base pairing with each other, we performed
SHAPE analysis of ISTL1-M4 RNA refolded and
probed in the presence of an ASO (ASO-M) that
targeted the mutated 30 strand of ISTL1 (from the 275th
to 297th positions of intron 7) (Figure 7B). As expected,
the presence of ASO-M increased the reactivity of residues
from the last position of exon 7 to the 14th position of
intron 7 [Figure 7A (compare lanes 7 and 8) and C (lower
panel)]. Interestingly, ASO-M had a much lesser effect on
accessibility of C residues at the 10th and 11th positions of
intron 7 [Figure 7A and C (lower panel)]. This could be
due to engagement of these residues in an alternative inter-
action when the 30 strand of ISTL1 is sequestered by ASO-
M. In addition, instances in which C residues in ﬂexible
regions display lower SHAPE reactivity than other
residues with similar apparent local structure have been
reported (45). Overall, our results provided the ﬁrst
validated example in which the sequestration of a deep
intronic sequence increased the accessibility of the 50 ss
of an exon.
We also compared the SHAPE proﬁles of the 30 strands
of ISTL1 in the wild-type and ISTL1-M4 RNAs.
Interestingly, we observed a signiﬁcant falloff of reverse
transcriptase (RTase) at positions 292 and 293 in the
mutant RNA in both control (DMSO) and 1M7 treated
samples that interfered with structure determination
(Supplementary Figure S2). We attribute these falloffs to
a combination of factors, including the presence of a strong
secondary structure (ISTL1) in front of the U-rich tract. To
obviate the RTase falloff, we modiﬁed our primer extension
reaction by adding an ASO (ASO-D), which is predicted to
disrupt ISTL1 by sequestering its 50 strand (Figure 8B).
Indeed, the presence of ASO-D fully prevented the falloff
of RTase at the 292nd and 293rd positions (Supplementary
Figure S2). These results provided additional evidence in
support of the formation of ISTL1. With the exception of
293G, residues from the 275th to 297th positions of intron
7 were poorly modiﬁable by 1M7 owing to their incorpor-
ation within ISTLs [Figure 8A (lane 5) and C (upper
panel)]. Yet, ISTL1-M4 RNA showed a further decrease
in 1M7 reactivity of residues from the 286th to 295th pos-
itions of intron 7 [Figure 8A (compare lanes 5 and 6) and C
(upper panel)]. Also, reactivity at the 298th and 299th pos-
itions decreased in the mutant ISTL1, whereas residues at
the 283rd to 285th positions located immediately upstream
of the strengthened ISTL1 became moderately to highly
modiﬁable [Figure 8A and C (upper panel)]. As expected,
the SHAPE proﬁle generated for the mutant RNA refolded
and probed with ASO-D showed an increase in the 1M7
reactivity of nucleotides from the 286th to 299th positions
of intron 7, with the exception of 291C [Figure 8A and C
(lower panel)]. To summarize, our results of structure
probing conﬁrmed the formation of ISTL1.
Effect of F14 and L14 on stability of ISTL1
To capture the effect of F14 and L14 on ISTL1 and other
structures of intron 7, we performed SHAPE analysis in
which we refolded the wild-type RNA in the presence of
F14 or L14 before incubation with 1M7. The SHAPE
proﬁles conﬁrmed the appropriate annealing of F14 and
L14 to their respective targets (Figure 9A). As the target
sites of both F14 and L14 overlap the 50 strand of the stem
in TSL3, we observed increased 1M7 reactivity of residues
from the 33rd to 41st positions of intron 7 in the presence
of either F14 or L14 [Figure 9A and B (upper and middle
panels)]. In addition, both ASOs caused an increase in
modiﬁability of some of the residues in the region that
encompasses the 50 strand of ISTL2 (Figure 9).
Importantly, F14 and L14 caused destabilization of the
region upstream of their annealing sites as indicated by
an increase in the modiﬁability of residues in the area ex-
tending to the two last positions of exon 7 (Figure 9).
Notably, F14 showed a greater destabilizing effect than
L14 (Figure 9B, lower panel).
The presence of F14, but not L14, resulted in a slight
increase in the modiﬁability of residues that constitute the
30 strand of ISTL1 (Supplementary Figure S3). Consistent
with the increased 1M7 reactivity of residues between the
50th and 58th positions of intron 7 (Figure 9), we also
observed increased modiﬁability of residues in the
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Figure 6. Secondary structure of SMN2 intron 7. (A) SHAPE-derived structure of SMN2 intron 7. This structure is based on combined results
produced with 10 extension primers (Supplementary Table S4). Large circles indicate nucleotides with normalized 1M7 reactivity >0.5, small circles
indicate nucleotides with normalized 1M7 reactivity between 0.3 and 0.5. Locations of modules, ISTLs and TSLs have been indicated. Positions
corresponding to RTase falloffs are marked with ‘F’. Nucleotides marked in red constitute a region with unconﬁrmed structure owing to multiple
falloffs. Alternative secondary structures of Module 1 (B) and Module 2 (C) as predicted by mfold. Descriptions of abbreviations are given in the
main body of the text as well as in the Supplementary Table S1.
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Figure 7. Validation of the engagement of the 50 strand of ISTL1 in structure formation. (A) SHAPE results for the 50 portion of intron 7 of the
wild-type and ISTL1-M4 mutant RNAs generated using Primer#10. Based on the sequencing ladders, positions of residues and locations of struc-
tures are marked on the gel. (B) Abridged mfold predicted structure of SMN2 intron 7. The probed structure is in agreement with the mfold predicted
structure. Nucleotide substitutions are shown in small-case letters and highlighted in red. Annealing site of ASO-M is indicated. Abbreviations are
the same as in Figure 6. (C) Alignment of raw peak proﬁles for the wild-type and mutant RNAs. Nucleotides that constitute the 50 strand of ISTL1
in the mutant RNA are marked. Peak proﬁles were generated using MultiGauge Software version 3.0 (FujiFilm).
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Figure 8. Validation of the engagement of the 30 strand of ISTL1 in structure formation. (A) SHAPE results for the middle portion of intron 7 of the
wild-type and ISTL1-M4 mutant RNA generated using Primer#17. Based on the sequencing ladders, positions of residues and locations of structures
are marked on the gel. (B) Abridged mfold-predicted structure of SMN2 intron 7. The probed structure is in agreement with the mfold-predicted
structure. Nucleotide substitutions are shown in small-case letters and highlighted in red. Annealing site of ASO-D is indicated. (C) Alignment of raw
peak proﬁles of the wild-type and mutant RNAs. Nucleotides that constitute the 30 strand of ISTL1 in the mutant RNA are marked. Peak proﬁles
were generated using MultiGauge Software version 3.0 (FujiFilm). RTase falloff products are marked by stars.
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complementary 30 strand of ISTL2 in the presence of both
ASOs, particularly at positions 284 and 285
(Supplementary Figure S3). A comparison of SHAPE
proﬁles did not reveal any novel secondary structure
whose formation was induced by annealing of either F14
or L14 to their respective targets. However, it is possible
that the minor structural differences induced by F14 and
L14 may be sufﬁcient to create distinct topological context
for the RNA-protein interactions.
Role of protein factors in 10C-mediated LDI
The abundantly expressed proteins hnRNP A1/A2B1 and
PTB1 have been implicated in skipping of SMN2 exon 7
(27). Owing to the proximity of ISS-N1 to ISTL1 in the
folded RNA, there is a probability that the in vivo inter-
action of hnRNP A1/A2B1 with ISS-N1 is facilitated by
ISTL1. It is also possible that hnRNP A1/A2B1 assists
folding of or stabilizes ISTL1. Considering the longest
U-rich tract of intron 7 is located immediately down-
stream of the LS-1 sequence (Figure 6), PTB1 may be
involved in ISTL1 formation as well. To explore
whether hnRNP A1/A2B1 and PTB1 are at all associated
with the 10C-mediated LDI, we ﬁrst depleted HeLa cells of
these proteins using a siRNA-based approach and then
transfected these cells with F14 or L14 followed by deter-
mination of splicing pattern of endogenous exon 7 from
both SMN1 and SMN2. To distinguish between SMN1
and SMN2 transcripts, we took advantage of a DdeI re-
striction site speciﬁc to SMN2 exon 8 (25). As expected,
depletion of either hnRNP A1 or A2B1 produced a no-
ticeable stimulatory effect on SMN2 exon 7 splicing
[Figure 10A and B (lanes 4 and 7)]. In particular, SMN2
exon 7 inclusion was substantially higher in hnRNP
A2B1-depleted compared with hnRNP A1-depleted cells.
However, the inhibitory effect of L14 on SMN2 exon 7
splicing was not abrogated by knockdown of hnRNP A1
and A2B1, individually or together (Figure 10, lanes 6, 9
and 12). Interestingly, depletion of hnRNP A2B1 alone or
together with hnRNP A1 produced more than a 3-fold
increase in L14-induced skipping of SMN2 exon 7
compared with only 2-fold increase when control
Figure 9. Effect of F14 and L14 on RNA secondary structure of SMN2 intron 7. (A) SHAPE results for the wild-type RNA probed in the presence
of F14 and L14. Primer#10 was used to identify 1M7 modiﬁcation sites. Based on the sequencing ladders, positions of residues and locations of
structures are marked on the gel. Annealing positions of F14 and L14 are marked by green and red bars, respectively. (B) Alignment of raw peak
proﬁles for the wild-type RNA refolded and probed with F14 or L14. Nucleotides that display higher reactivity toward 1M7 in the presence of F14
and L14 are indicated. The region where nucleotides are more reactive with 1M7 in the presence of F14 than in the presence of L14 is indicated by an
arrow.
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siRNA-treated HeLa cells were transfected with L14
(Figure 10B, compare lane 3 with lanes 6, 9 and 12). As
hnRNP A1 and A2B1 are involved in several other
processes, including but not limited to transcription and
microRNA biogenesis (47), we attribute these differences
to indirect factors. Similar to hnRNP A1/A2B1, depletion
of PTB1 did not eliminate the inhibitory effect of L14 on
SMN2 exon 7 splicing (Figure 10B, lane 15). Therefore,
our results clearly ruled out the role of hnRNP A1/A2B1
and PTB1 in the 10C-mediated LDI.
ISTL1 as a potential therapeutic target for splicing
correction in SMA
The widely used GM03813 cell line (SMA type I ﬁbro-
blasts) contains only SMN2 and provides an ideal
cell-based disease model to check the efﬁcacy of com-
pounds to modulate SMN2 exon 7 splicing in vivo. To
evaluate the impact of ISTL1 in the context of the en-
dogenous gene, we transfected GM03813 cells with
ASOs that annealed to overlapping intronic targets en-
compassing the 30 strand of ISTL1 and neighboring se-
quences. To avoid off-target effects, we performed this
experiment at a low nanomolar (15 nM) concentration of
ASOs. Supporting the inhibitory nature of ISTL1, ASOs
that sequestered the 30 strand of ISTL1 promoted SMN2
exon 7 inclusion (Figure 11A, lanes 4–8). ASO 283-297,
which sequestered the entire 30 strands of ISTL1 and
ISTL2, emerged as the most effective ASO, whose stimu-
latory effect was comparable with that of F14,
which targeted ISS-N1 (Figure 11A, lanes 6 and 11).
Figure 10. Effect of depletion of hnRNP A1/A2B1 and PTB1 on 10C-mediated LDI. (A) Western blot results showing the effect of indicated siRNAs
on the level of corresponding proteins. (B) Splicing pattern of the endogenous SMN exon 7 in the presence of the control ASO (10mer), F14 and L14
in HeLa cells treated with different siRNAs. Control ASO was the same as described in Figure 2. Spliced products ampliﬁed by RT-PCR were
digested with DdeI to distinguish between the transcripts from SMN1 and SMN2 pre-mRNA (25). 30Ex8 represents the cleavage product of DdeI
digestion of SMN2 exon 8. The percentage of SMN2 exon skipping was calculated as in (28).
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ASO 276–290, which predominantly targeted the 30
strands of ISTL2 and ISTL3, also stimulated exon 7 in-
clusion, albeit to a substantially lower extent (Figure 11A,
lane 4). This reduced response may be due in part to
partial destabilization of the neighboring ISTL1 and/or
TSL3. For the convenience of distinction from our previ-
ously reported antisense target ISS-N1 (34), we designate
sequences from the 275th to 297th position of intron 7 as
ISS-N2 (Figure 11A, upper panel). The inhibitory nature
of ISS-N2 is fully supported by the results of antisense
microwalk (Figure 11A) and the overlapping deletions
(Figures 2 and 3). Similar to ASO 283–297, a 23 nt long
ASO that fully sequestered ISS-N2 stimulated exon 7
inclusion (not shown).
We also examined the effect of ASO 283–297 on the
levels of SMN in SMA patient cells. As a positive
control, we used a 20mer ASO (Anti-N1) that is known
to stimulate SMN2 exon 7 inclusion by binding to ISS-N1
(34). As a negative control, we used a 10mer ASO
described previously (40). We transfected GM03813 cells
with 40 nM of a given ASO and determined the splicing
pattern of SMN2 exon 7 as well as the protein levels at
48 h post-transfection. As expected, ASO 283–297 effect-
ively stimulated SMN2 exon 7 inclusion and upregulated
SMN protein levels in SMA patient cells (Figure 11B). We
also observed a noticeable increase in the level of SMN-
interacting protein Gemin2 (Figure 11B, left panel). The
stimulatory effect of ASO 283–297 on SMN2 exon 7
Figure 11. Effect of ASOs on splicing of endogenous SMN2 exon 7 in SMA patient cells. (A) Diagrammatic representation of the region of intron 7
targeted by the indicated ASOs. Numbering of nucleotides starts from the beginning of intron 7. Areas corresponding to the 30 strands of ISTLs as
well as ISS-N2 are indicated. ASOs are shown as horizontal bars. ASO name indicates the ﬁrst and the last position of their target site in intron 7.
SMA patient ﬁbroblasts (GM03813) were transfected with 15 nM of a given ASO and total RNA was harvested at 24 h post transfection. Control
ASO was the same as described in Figure 2. Results were analyzed as described in (35). (B) Effect of the stimulatory ASOs on levels of cellular
proteins in SMA patient cells. GM03813 cells were transfected with 40 nM of a given ASO, and cells were harvested at 48 h post-transfection.
Splicing pattern and protein levels were determined as in (35).
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splicing and levels of SMN and Gemin2 was comparable
with that of Anti-N1 (Figure 11B). Taken together, these
results represent the ﬁrst example in which an ASO an-
nealing to a deep intronic sequence corrects aberrant
splicing and restores high levels of a full-length protein
in a cell-based model of a genetic disease.
DISCUSSION
SMA is the leading genetic cause of infant mortality. The
disease has the potential to be corrected through preven-
tion of SMN2 exon 7 skipping. Our previous discovery of
the 15 nt long ISS-N1 has emerged as the most promising
target for an ASO-mediated restoration of SMN2 exon 7
inclusion (34–39). This study began with the aim to
uncover how two 14mer ISS-N1-targeting ASOs (F14
and L14) produced opposite effects on alternative
splicing of SMN2 exon 7. We established that the inhibi-
tory effect of L14 is exclusively linked to the unsequestered
10C and is contingent on the presence of a downstream
intronic sequence separated from 10C by hundreds of nu-
cleotides; there was no precedence of any similar ﬁnding.
To identify the motif associated with the 10C-mediated
LDI, we adopted an unbiased approach in which we
tested the effect of L14 on splicing of SMN2 minigene
mutants harboring large deletions and 20 nt long
overlapping deletions within the entire 30-half of intron
7. Our results delineated a single 19 nt long sequence
stretch from the 282nd to 300th positions of intron 7 as
the primary site of the LDI associated with 10C (Figure 2).
Subsequent screening of minigenes with shorter
overlapping deletions and with point mutations
narrowed the site of the LDI to a 6 nt long motif (LS-1)
that spans from the 290th to 295th positions of intron 7
(Figures 3 and 4). LS-1 is located within the 30 strand of an
mfold-predicted structure we term ISTL1 (Figure 4A). The
50 strand of ISTL1 harbors 10C, which base pairs with the
ﬁrst residue (290G) of LS-1 (Figure 4A). Another motif
identical to LS-1 (GCAGAC) spans the 282nd to 287th
positions of intron 7. Interestingly, deletion of LS-1
(290–295) and not the identical upstream sequence
(282–287) abrogated the formation of ISTL1 and led
to the complete loss of the inhibitory effect associated
with L14 (Supplementary Figure S1). These results
underscored the critical role of structural context of LS-
1 for the realization of the inhibitory effect associated with
10C. Consistent with this statement, all intronic deletions
that retained the inhibitory effect of L14 maintained the
formation of ISTL1.
Compared with ISS-N1 deletion that produced a strong
stimulatory effect on SMN2 exon 7 splicing (34), deletion
of LS-1 and intronic sequences immediately upstream of
LS-1 produced a moderate but noticeable stimulatory
effect on exon 7 splicing [Figure 2B, lanes 7, 10 and 13;
Figure 3A, lanes 7, 10, 13 and 16; Figure 3B (lanes 7, 10,
13 and 16) and C (lanes 13 and 16)]. However, owing to
potential creation of artiﬁcial cis-element and/or reloca-
tion of the existing cis-elements, results of deletion muta-
tions should be interpreted with caution. For instance, as
deletion of LS-1 and sequences immediately upstream of
LS-1 still retained ISS-N1 that kept the TIA1 binding site
away from the 50 ss of exon 7, it did not have the similar
additive stimulatory effect on SMN2 exon 7 splicing as
was observed in case of ISS-N1 deletion. Nonetheless,
our results of deletion mutations combined with the
enhanced stimulatory effects of F14/L14 on SMN2 exon
7 splicing produced sufﬁcient enough lead for the identi-
ﬁcation of ISTL1 that we determined to be the sole facili-
tator of a unique LDI associated with 10C. Interestingly,
262–281 and 301–320 mutants showed a noticeable
increase in SMN2 exon 7 skipping (Figure 2B, lanes 4
and 16). This could be due to the loss of stimulatory cis-
elements in these mutants. It is also possible that these
mutants somehow strongly enforce the formation of
ISTL1.
The strongest evidence supporting the role of the ISTL1
structure in the 10C-mediated LDI came from the results
of compensatory mutations. For example, 8C/292G and
10G/290C mutations, which altered the composition of
ISTL1 but maintained the structure, were able to restore
the inhibitory effect of L14 (Figure 5B). These results also
precluded the role of a linear motif encompassing the 10th
position of intron 7 in 10C-mediated LDI. Although
competing intronic RNA secondary structures have been
predicted to play a positive role in the selection of
mutually exclusive exons during splicing of the insect
Dscam pre-mRNA (8), our results of compensatory mu-
tations provide the ﬁrst validated evidence that an intra-
intronic RNA secondary structure formed by a LDI can
play a negative role in splicing regulation. Previous studies
have suggested that the weak 50 ss of SMN2 exon 7 is due
to the presence of a local secondary structure (TSL2) and
the close proximity of the 50 ss to hnRNP A1/A2B1
binding motifs within ISS-N1 (16,26–28,48). The 50
strand of ISTL1 sequesters four of the six residues
involved in base pairing with U1 snRNA, a component
of U1 snRNP, recruitment of which is critical for the def-
inition of the 50 ss of exon 7 [(16), Figure 12]. Supporting
the negative role of ISTL1, mutations that extended the
length of ISTL1 led to an increased skipping of SMN2
exon 7 (Figure 5A). Therefore, our discovery of ISTL1
reveals an additional layer of control of SMN2 exon 7
splicing, where a deep intronic sequence may affect re-
cruitment of U1 snRNP by a direct interaction with the
50 ss.
Having determined the functional signiﬁcance of
ISTL1, we next performed SHAPE analysis of a large
RNA substrate harboring the entire intron 7 and the
upstream exonic sequences encompassing TSL2. We also
compared the structure of the wild-type RNA with the
ISTL1-M4 mutant that possessed a signiﬁcantly
strengthened ISTL1. The results of structure probing
validated the formation of ISTL1. Consistently, the
ISTL1-M4 mutant, predicted to greatly extend the
length of ISTL1, showed protection of additional
residues involved in the extension of the 50 and 30
strands of ISTL1 (Figures 7 and 8). The SHAPE proﬁle
of ISTL1-M4 conﬁrmed that mutations deep inside intron
7 are able to affect the structure of a region located
hundreds of nucleotides away, which is possible only
when ISTL1 is formed (Figures 7 and 8). Overall, the
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pattern of 1M7-modiﬁed positions supported that intron 7
folds into a complex structure, including the formation of
multiple adjacent helices (Figure 6). Considering residues
at the interface of adjacent helices generate co-axial
stacking that imposes topological constraints on 3D
helix organization (49–51), we predict the existence of
complex tertiary interactions involving loop-to-loop
contacts. Consistently, SHAPE results indicated the
presence of large terminal and internal loops as well as
extended single-stranded regions. Interestingly, two of
the three reported intronic binding sites of hnRNP A1/
A2B1 were localized in the structurally accessible regions
of intron 7 (Figure 6). On the other hand, most of the
U-rich motifs associated with TIA1 were trapped within
stems of TSL3 and ISTL2 (Figure 6). Our ﬁndings suggest
that the structural context of intron 7 is not conducive for
the recruitment of TIA1, a critical positive regulator of
SMN2 exon 7 splicing (28). Of note, TIA1 is the sole
splicing factor whose mutation has been recently linked
to defective SMN2 exon 7 splicing in the context of a
genetic disease (52).
ISTL1 formation requires looping out of a 279 nt
sequence, of which 189 residues are occupied by the inde-
pendently folding Modules 1 and 2 (Figure 6). A 147 nt
long sequence downstream of ISTL1 contains another in-
dependently folding module (Module 3) that occupies 89
residues of intron 7 (Figure 6). Simultaneous deletion of
Modules 1, 2 and 3 reduced the size of intron 7 by more
than half and yet preserved the inhibitory effect of L14
(Figure 2). These results demonstrate that the formation
of ISTL1 is independent of most of the local secondary
structures within intron 7. However, the relative position-
ing of ISTL1 with respect to ISTL2 appears to modulate
other local structures, particularly TSL3. This is evident in
the ISTL1-M4 mutant, in which residues involved in the
formation of TSL3 become modiﬁable by 1M7 (Figure 7).
Of note, strengthening of ISTL1 in this mutant did not
sequester residues directly engaged in TSL3 formation and
yet led to perturbation of TSL3. An increase in length of
the ISTL1 helix in the ISTL1-M4 mutant also destabilized
ISTL2 (Figures 7 and 8). These results suggest that the
ISTL1 and ISTL2 in the wild-type context have stabilizing
roles in folding of local structures. Such roles for these
structures would be analogous to tertiary interactions
that are known to dictate the accuracy of local folding
(50).
On comparing the 1M7 modiﬁcation proﬁles of RNA
refolded and probed in the presence of F14 and L14, we
observed a link between destabilization of ISTL1 and a
stimulatory effect of the ASOs on SMN2 exon 7 splicing.
Although both F14 and L14 are predicted to generate a 14
bp long helix when bound to their respective targets, the
F14 helix also invades ISTL1. Therefore, we found that
F14 caused a somewhat greater increase in 1M7
modiﬁability of residues associated with ISTL1 as
compared with L14 (Figure 9). It is possible that the co-
axial stacking of residues at the interface of the L14-
duplex and ISTL1 brings topological constraint that
prevents recruitment of U1 snRNP at the 50 ss of exon
7. Consistently, substitution at the 10th intronic position
has been shown to fully eliminate the inhibitory effect of
L14 (40). Although both F14 and L14 disrupt TSL3, the
constraint of co-axial stacking at the interface of ISTL1
and L14-duplex are likely to provide a different orienta-
tion of the TIA1-binding site located within the disrupted
TSL3. Therefore, the inhibitory effect of L14 might be due
to the unfavorable conformational changes that prevent
recruitment of positive regulatory factors.
Previous reports have implicated hnRNP A1/A2B1 and
PTB1 in skipping of SMN2 exon 7 (27,28,48).
Incidentally, these abundantly expressed proteins are
also involved in a looping mechanism that brings distantly
located intronic motifs in close proximity (2,53). To
examine whether the inhibitory effect of L14 is linked to
hnRNP A1/A2B1 and/or PTB1, we assessed the effect of
L14 on splicing of endogenous SMN2 exon 7 in HeLa cells
depleted of these proteins. Our results did not reveal any
signiﬁcant change in the negative effect of L14, suggesting
that these proteins are not involved in L14-induced
skipping of SMN2 exon 7 (Figure 10). Based on our
results, it is likely that the ISTL1-assisted sequestration
of the 50 ss is a sufﬁcient enough trigger to promote
SMN2 exon 7 skipping. RNA helicases that bind and/or
change the orientation of a RNA helix have been
implicated in regulation of alternative splicing in patho-
logical conditions (54,55). Future experiments will deter-
mine whether RNA helicases affect SMN2 exon 7 splicing
by targeting ISTL1.
Having determined that ISTL1 imparts a negative effect
on SMN2 exon 7 splicing by sequestration of the 50 ss of
exon 7, we next evaluated the potential of ISTL1 as a
target for an ASO-mediated splicing correction in SMA
patient cells. Sequestration of the 30 strand of ISTL1 by an
ASO is predicted to make the 50 ss of SMN2 exon 7 ac-
cessible for base pairing to U1 snRNA, a component of
U1 snRNP (Figure 12). In addition, TIA1 is known to
enhance the recruitment of U1 snRNP to the 50 ss of
exons (56). Therefore, we hypothesize that the sequestra-
tion of the 30 strand of ISTL2 might also promote U1
snRNP recruitment by releasing TIA1-binding sites
located within the helices of ISTL2 and TSL3
(Figure 12). Hence, we expected to see a better stimulatory
effect on SMN2 exon 7 splicing when the 30 strands of
ISTL1 and ISTL2 were sequestered simultaneously.
Indeed, a 15 nt long ASO (ASO 283–297) that targeted
the 30 strands of ISTL1 and ISTL2 signiﬁcantly increased
SMN2 exon 7 inclusion (Figure 11A). Consistent with the
stimulatory effect of ASO 283–297 on SMN2 exon 7
splicing, this ASO also increased the levels of SMN in
SMA patient cells (Figure 11B). SMN has high afﬁnity
for Gemin2. SMN:Gemin2 interaction has been con-
sidered to be one of the critical steps for the assembly of
all SMN complexes (57,58). Consistent with the increase
in SMN, we found increased levels of Gemin2 in SMA
patient cells treated with ASO 283–297. Most importantly,
the stimulatory effect of ASO 283–297 was found to be
comparable with Anti-N1, a 20mer ASO that targets
ISS-N1.
Although we have used only a 15mer ASO to demon-
strate the therapeutic potential of a deep intronic target,
our results of deletion mutations support a larger inhibi-
tory region that we term ISS-N2, which encompasses the
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30 strands of ISTL1, ISTL2 and ISTL3 (Figure 11A).
Therefore, different oligonucleotide chemistries, particu-
larly those that work better for longer ASOs, may be
more useful when targeting the entire ISS-N2. Presently,
SMA has no cure. An ISS-N1-targeting ASO with
phosphorothioate backbone and 2-O-methoxyethyl
(MOE) modiﬁcation, a proprietary of ISIS Pharma-
ceuticals, is currently undergoing the 2nd phase of
clinical trial (Clinicaltrials.gov ID NCT01839656). For
SMA therapy, our ﬁnding of ISS-N2 comes at a time
when lack of additional targets has prevented clinical
trials of ASOs with other promising chemistries that
have shown encouraging results in recent pre-clinical
and clinical trials (39,59). There is a substantial difference
in sequence composition between ISS-N1 and ISS-N2. In
view of the fact that sequence composition alone can
affect pharmacokinetics and pharmacodynamics of an
ASO, availability of ISS-N2 as a novel target has add-
itional signiﬁcance for developing an entirely new class
of therapeutic ASOs for the treatment of SMA.
The coding sequence of mammalian SMN is mostly
conserved. However, there is a noticeable divergence
among intronic sequences. For example, mouse Smn
intron 7 is 1640 nt long, whereas human SMN intron 7
is only 444 nt long. In addition to the absence of ISS-N1,
mouse Smn intron 7 lacks 10C (34). Consistently, the
mfold-predicted structure of mouse Smn intron 7 did not
reveal a structure analogous to ISTL1/ISTL2/ISTL3 (not
shown). Our results combined with the prior reports
clearly suggest an evolutionarily distinct intra–intronic
regulatory network that ﬁne tunes and modulates with
utmost precision the splicing of human SMN exon 7
[Figures 6 and 12, Supplementary Figure S4, (32)].
Currently, the literature is replete with studies that focus
on linear cis-elements, particularly in the beginning of
introns (60,61). Our ﬁndings suggest that the information
content of a linear cis-element at the beginning of intron
can be tightly controlled by a deep intronic sequence.
About 50% of all genetic disorders are caused by muta-
tions that alter pre-mRNA splicing (62). Intronic se-
quences occupy a major portion (26%) of human
genome and represent 94% of pre-mRNA (63). There
is growing appreciation that a signiﬁcant portion of the
transcriptome’s regulatory information is trapped in sec-
ondary and high-order RNA structures (64). Our discov-
ery of ISTL1 provides the proof of principle how the
structural information locked in the deep intronic
sequence could impact the context of the 50 ss, which is
often populated by a multitude of linear cis-elements. Our
results also demonstrate that an ASO-mediated sequestra-
tion of a deep intronic sequence could remodel the 50 ss by
disrupting a LDI associated with an RNA structure.
While these ﬁndings undoubtedly advance our under-
standing of splicing regulation in SMA, they also signify
the enormous potential for uncovering the structure-
associated regulatory network of general splicing.
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